(Q45126003)

9 December 2017

title

Clinical trials of radiosensitizers: what should we expect? (English)

1 reference

9 December 2017

Clinical trials of radiosensitizers: What should we expect? (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

2 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

2 September 2023

author name string

J. M. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6231272

2 September 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

full work available at URL

9 December 2017

https://api.elsevier.com/content/article/PII:0360301684900634?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

https://api.elsevier.com/content/article/PII:0360301684900634?httpAccept=text/plain

2 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

International Journal of Radiation Oncology Biology Physics

2 September 2023

published in

1 reference

9 December 2017

volume

10

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

425-429

1 reference

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers

9 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents

2 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole

2 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizers

2 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use

2 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione

2 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Interaction of misonidazole and oxygen in the radiosensitization of mammalian cells

2 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Selection of appropriate studies for phase III trials of radiosensitizers

2 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Effect of oxygen-radiosensitizer mixtures on the radiation response of Chinese hamster cells, line V.79-753B, in vitro. I. Survival response

2 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells

2 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo

2 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Survival measurements at low doses: oxygen enhancement ratio

2 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

A serial study of the concentration of misonidazole in human tumors correlated with histologic structure

2 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Misonidazole enhancement of radiation-induced growth delay in rat rhabdomyosarcoma tumours exposed to accelerated carbon and neon ions

2 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer

2 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

A rapid-mixing comparison of the mechanisms of radiosensitization by oxygen and misonidazole in CHO cells.

2 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole

2 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

Sensitizing and toxicity properties of misonidazole and its derivatives

2 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

In vivo assessment of basic 2-nitroimidazole radiosensitizers

2 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90063-4

2 September 2023

Identifiers

1 reference

9 December 2017

1 reference